Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,786

Class I recallsReasonable probability of serious health consequences

24,313

Class II recallsTemporary or medically reversible health consequences

2,876

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026

Most affected stateHawaii 200 recalls mention this state

State: PR ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 12, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

FDA Recall Terminated Historical recordClass II

Ropinirole, USP, 1 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

by Direct Rx

Reason: cGMP deviations
Published: April 5, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ropinirole, USP, 0.25 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

by Direct Rx

Reason: cGMP deviations
Published: April 5, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Finasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged and Distributed By: Direct Rx

by Direct Rx

Reason: cGMP deviations
Published: April 5, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Montelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC 61919-0009-30; b) 90-count bottle, NDC 61919-0009-90; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

by Direct Rx

Reason: cGMP deviations
Published: April 5, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.

by Endo Pharmaceuticals, Inc.

Reason: Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
Published: April 5, 2023
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

THE ISH COMPANY

Product: ISH Shrimpish Sample Meal Kit: ( Sample Meal Kit ) a package…
Reason: undeclared soy proteins
Published: April 5, 2023
Distribution: Multiple states

View recall →

FDA Recall United States Terminated Historical recordClass II

BINDLE BOTTLE

Product: Stainless Steel Water Bottle The product comes in four sizes…
Reason: Water bottle has a cup with a screw cap attached by a weld that has been found to leach lead.
Published: April 5, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Delsam Pharma's Artificial Eye Ointment (Mineral Oil 15%, White Petrolatum 83%), 3.5 grams (1/8 oz.) tube, Distributed By: Delsam Pharma Lic, Bronx, Newyork 10469, NDC 72570 122 35, UPC 3 72570 12235 3.

by Global Pharma Healthcare Private Limited

Reason: Non-Sterility: FDA analysis found unopened tubes to be contaminated with bacteria.
Published: March 29, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 47335-0063-86

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason: Failed Content Uniformity Specifications
Published: March 29, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5555-3

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for shear.
Published: March 29, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5554-3.

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for shear.
Published: March 29, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for shear.
Published: March 29, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for shear.
Published: March 29, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) bottles, Rx only, Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA and Eli Lilly and Company Indianapolis, IN 46285 USA

by Boehringer Ingelheim Pharmaceuticals, Inc.

Reason: Labeling: Label Mix-up
Published: March 29, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl oz) bottle, Sterile, Distributed by Medtech Products Inc. Tarrytown, NY 10591, A Prestige Consumer Healthcare company, Made in Israel, UPC 678112000708; NDC 67172-504-01.

by Teva Pharmaceuticals USA Inc

Reason: Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.
Published: March 22, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC 60505-7079-05

by AVEVA Drug Delivery Systems, Inc.

Reason: Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Published: March 22, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Buprenorphine Transdermal System, CIII 10 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC 60505-7077-05

by AVEVA Drug Delivery Systems, Inc.

Reason: Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Published: March 22, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan, Minnapolis, MN 55427, NDC: 0574-2067-27

by Padagis US LLC

Reason: Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.
Published: March 22, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clobazam Tablets, 20 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-901-01

by Breckenridge Pharmaceutical, Inc

Reason: CGMP Deviations: Potential risk of Cross Contamination
Published: March 22, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clobazam Tablets, 10 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-900-01

by Breckenridge Pharmaceutical, Inc

Reason: CGMP Deviations: Potential risk of Cross Contamination
Published: March 22, 2023
Distribution: Nationwide

View recall →

Data last updated: September 12, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.